ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977

Report Says Many Cancers Could Be Prevented

February 27, 2009

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

NCI FY94 Budget By Mechanism Under House, Senate Mark

September 24, 1993

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980